Anti-neutrophil Cytoplasmic Antibody-negative Eosinophilic Granulomatosis with Polyangiitis Complicated with Peripheral Neuropathy That Underwent Remission Induction with Mepolizumab Monotherapy

Overview

Journal Intern Med

Specialty General Medicine

Date 2023 Feb 1

PMID 36725044

Authors

Masahiro Nishihara

Midori Suzuki

Shinya Asatani

Yosuke Nagasawa

Masako Tsukamoto

Kumiko Akiya

Hitomi Kobayashi

Noboru Kitamura

Hideki Nakamura

Affiliations

Soon will be listed here.

Abstract

A 72-year-old woman was admitted to our hospital with numbness in her lower extremities and hypereosinophilia. She was diagnosed with eosinophilic granulomatosis with polyangiitis (EGPA). On admission, she was suspected of being complicated with pneumonia and sepsis; therefore, treatment with mepolizumab monotherapy was begun, resulting in partial improvement. After the possibility of a complicating infection was ruled out, corticosteroids were initiated, followed by intravenous gamma globulin therapy. Although the induction of remission of EGPA with mepolizumab monotherapy is not usually recommended, induction with mepolizumab monotherapy may be an option in terms of safety and clinical efficacy in some cases.

References

Khatri S, Moore W, Gibson P, Leigh R, Bourdin A, Maspero J . Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma. J Allergy Clin Immunol. 2018; 143(5):1742-1751.e7. DOI: 10.1016/j.jaci.2018.09.033. View

MASI A, Hunder G, Lie J, Michel B, Bloch D, Arend W . The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990; 33(8):1094-100. DOI: 10.1002/art.1780330806. View

Joo K, Park W, Lim M, Kwon S, Yoon J . Serum procalcitonin for differentiating bacterial infection from disease flares in patients with autoimmune diseases. J Korean Med Sci. 2011; 26(9):1147-51. PMC: 3172650. DOI: 10.3346/jkms.2011.26.9.1147. View

Nishihara M, Hamaguchi M, Ikumi N, Nishiwaki A, Sugiyama K, Nagasawa Y . Successful early introduction of mepolizumab for peripheral neuropathy with a peripheral circulatory disorder in a patient with myeloperoxidase anti-neutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis. Mod Rheumatol Case Rep. 2021; 5(2):354-359. DOI: 10.1080/24725625.2021.1916159. View

Sada K, Amano K, Uehara R, Yamamura M, Arimura Y, Nakamura Y . A nationwide survey on the epidemiology and clinical features of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) in Japan. Mod Rheumatol. 2013; 24(4):640-4. DOI: 10.3109/14397595.2013.857582. View

Aikawa N, Fujishima S, Endo S, Sekine I, Kogawa K, Yamamoto Y . Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother. 2005; 11(3):152-9. DOI: 10.1007/s10156-005-0388-9. View

Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S . Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis. 2008; 68(12):1827-32. DOI: 10.1136/ard.2008.101279. View

Oka N . [Pathology of Vasculitic Neuropathies]. Brain Nerve. 2016; 68(3):223-31. DOI: 10.11477/mf.1416200381. View

Wechsler M, Akuthota P, Jayne D, Khoury P, Klion A, Langford C . Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis. N Engl J Med. 2017; 376(20):1921-1932. PMC: 5548295. DOI: 10.1056/NEJMoa1702079. View

10.

Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P . Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore). 1999; 78(1):26-37. DOI: 10.1097/00005792-199901000-00003. View

11.

Tsubouchi H, Tsuchida S, Yanagi S, Shigekusa T, Miura M, Sakaguchi K . Successful treatment with mepolizumab in a case of allergic bronchopulmonary aspergillosis complicated with nontuberculous mycobacterial infection. Respir Med Case Rep. 2019; 28:100875. PMC: 6558237. DOI: 10.1016/j.rmcr.2019.100875. View

12.

Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P . The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore). 2011; 90(1):19-27. DOI: 10.1097/MD.0b013e318205a4c6. View

13.

Kitamura N, Hamaguchi M, Nishihara M, Ikumi N, Sugiyama K, Nagasawa Y . The effects of mepolizumab on peripheral circulation and neurological symptoms in eosinophilic granulomatosis with polyangiitis (EGPA) patients. Allergol Int. 2020; 70(1):148-149. DOI: 10.1016/j.alit.2020.08.005. View

14.

Mathew L, Talbot K, Love S, Puvanarajah S, Donaghy M . Treatment of vasculitic peripheral neuropathy: a retrospective analysis of outcome. QJM. 2006; 100(1):41-51. DOI: 10.1093/qjmed/hcl125. View

15.

Ortega H, Liu M, Pavord I, Brusselle G, FitzGerald J, Chetta A . Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med. 2014; 371(13):1198-207. DOI: 10.1056/NEJMoa1403290. View

16.

Koike H, Akiyama K, Saito T, Sobue G . Intravenous immunoglobulin for chronic residual peripheral neuropathy in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a multicenter, double-blind trial. J Neurol. 2015; 262(3):752-9. PMC: 4363522. DOI: 10.1007/s00415-014-7618-y. View

17.

Pradhan R, Nepal G, Mandal S . Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis. Pulm Med. 2019; 2019:4376380. PMC: 6421039. DOI: 10.1155/2019/4376380. View

18.

Oka N, Kawasaki T, Matsui M, Shigematsu K, Unuma T, Sugiyama H . Two subtypes of Churg-Strauss syndrome with neuropathy: the roles of eosinophils and ANCA. Mod Rheumatol. 2010; 21(3):290-5. DOI: 10.1007/s10165-010-0400-9. View

19.

Chung S, Langford C, Maz M, Abril A, Gorelik M, Guyatt G . 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2021; 73(8):1366-1383. DOI: 10.1002/art.41773. View

20.

Sinico R, Di Toma L, Maggiore U, Bottero P, Radice A, Tosoni C . Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum. 2005; 52(9):2926-35. DOI: 10.1002/art.21250. View